OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SRHL56

Sree Rayalaseema Hi-Strength Hypo Ltd

Commodity ChemicalsVerified

The company maintains a strong liquidity position with a current ratio of 8.99, indicating a high ability to meet short-term obligations. However, the liquidity risk is assessed as medium, and the company reports negative net cash after subtracting total debt, suggesting potential short-term cash flow constraints. Profitability metrics show a return on equity (ROE) of 9.81% and a return on assets (ROA) of 8.42%, which are strong indicators of efficient capital use and asset management. These figures are above the typical thresholds for the Commodity Chemicals industry, suggesting the company is outperforming its peers in terms of profitability. The company's revenue is distributed across three segments: Chemicals, Trading, and Power Generation. The Chemicals segment is the primary revenue driver, with a significant portion of the company's operations concentrated in this area. The geographic exposure is primarily within India, with a notable export component, though the exact distribution of export revenue is not disclosed. The company's growth trajectory is positive, with a free cash flow of INR 869.33 million and a capital expenditure of INR -24.34 million, indicating a focus on maintaining operations rather than aggressive expansion. The outlook for the current fiscal year suggests continued operational efficiency, with a net income of INR 900.72 million and an operating income of INR 838.65 million. Risk factors include a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.02, indicating a conservative capital structure with minimal leverage. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics, suggesting a stable equity position. Recent events include the company's ongoing operations in chemical manufacturing, coal trading, and power generation. No specific recent filings or transcripts have been disclosed in the provided data, but the company's activities remain consistent with its core business segments.

30-day price · SRHL+117.50 (+27.9%)
Low$382.40High$558.35Close$538.55As of12 May, 00:00 UTC
Profile
CompanySree Rayalaseema Hi-Strength Hypo Ltd
TickerSRHL.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Sree Rayalaseema Hi-Strength Hypo Ltd is an India-based company engaged in the manufacturing of chemicals, coal trading, and power generation through wind, solar, and thermal sources, with manufacturing plants located in Andhra Pradesh.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

The company maintains a strong liquidity position with a current ratio of 8.99, indicating a high ability to meet short-term obligations. However, the liquidity risk is assessed as medium, and the company reports negative net cash after subtracting total debt, suggesting potential short-term cash flow constraints. Profitability metrics show a return on equity (ROE) of 9.81% and a return on assets (ROA) of 8.42%, which are strong indicators of efficient capital use and asset management. These figures are above the typical thresholds for the Commodity Chemicals industry, suggesting the company is outperforming its peers in terms of profitability. The company's revenue is distributed across three segments: Chemicals, Trading, and Power Generation. The Chemicals segment is the primary revenue driver, with a significant portion of the company's operations concentrated in this area. The geographic exposure is primarily within India, with a notable export component, though the exact distribution of export revenue is not disclosed. The company's growth trajectory is positive, with a free cash flow of INR 869.33 million and a capital expenditure of INR -24.34 million, indicating a focus on maintaining operations rather than aggressive expansion. The outlook for the current fiscal year suggests continued operational efficiency, with a net income of INR 900.72 million and an operating income of INR 838.65 million. Risk factors include a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.02, indicating a conservative capital structure with minimal leverage. The dilution potential is low, and no significant adjustments have been applied to the valuation metrics, suggesting a stable equity position. Recent events include the company's ongoing operations in chemical manufacturing, coal trading, and power generation. No specific recent filings or transcripts have been disclosed in the provided data, but the company's activities remain consistent with its core business segments.
Key takeaways
  • The company has a strong liquidity position with a current ratio of 8.99.
  • ROE and ROA are above industry norms, indicating efficient capital and asset use.
  • Revenue is primarily driven by the Chemicals segment, with a significant export component.
  • The company maintains a conservative capital structure with a low debt-to-equity ratio.
  • Growth is focused on operational efficiency rather than aggressive expansion.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue$6.38B
Gross profit$2.81B
Operating income$838.6M
Net income$900.7M
R&D
SG&A
D&A
SBC
Operating cash flow$654.8M
CapEx-$24.3M
Free cash flow$869.3M
Total assets$10.70B
Total liabilities$1.51B
Total equity$9.18B
Cash & equivalents
Long-term debt$157.4M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.18B
Net cash-$157.4M
Current ratio9.0
Debt/Equity0.0
ROA8.4%
ROE9.8%
Cash conversion73.0%
CapEx/Revenue-0.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricSRHLActivity
Op margin13.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin14.1%2.3% medp25 -11.6% · p75 11.8%top quartile
Gross margin44.0%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity2.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:19 UTC#dfd593eb
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 09:21 UTCJob: 3fccc32e